41
/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
May 31, 2026
2135679
178559
2
Create a timeline
Public Timelines
For organizations
For companies
For educational institutions
For teachers
For students
Dashboard
For educational institutions
For teachers
For students
Dashboard
FAQ
Close
Create a timeline
Public timelines
FAQ
About & Feedback
Terms
Privacy
FAQ
Support 24/7
Dashboard
Get premium
Donate
may 16, 2018 - FDA approved Lucemyra (lofexidine hydrochloride), the first non-opioid treatment for the mitigation of withdrawal symptoms associated with abrupt discontinuation of opioids.
Added to timeline:
Opioids and the FDA
By
Anastasia
13 Nov 2018
0
0
549
Date:
may 16, 2018
Now
~ 8 years ago
About & Feedback
Terms
Privacy
FAQ
Support 24/7
Dashboard
Get premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
